nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—CYP3A4—bone cancer	0.38	1	CbGaD
Levothyroxine—SLCO4C1—Methotrexate—bone cancer	0.186	0.337	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—bone cancer	0.131	0.237	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—bone cancer	0.073	0.132	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—bone cancer	0.0451	0.0817	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—bone cancer	0.0425	0.0771	CbGbCtD
Levothyroxine—ALB—Methotrexate—bone cancer	0.0233	0.0422	CbGbCtD
Levothyroxine—ABCB1—Cisplatin—bone cancer	0.0188	0.034	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—bone cancer	0.0126	0.0228	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—bone cancer	0.0122	0.0221	CbGbCtD
Levothyroxine—CYP3A4—Doxorubicin—bone cancer	0.00753	0.0137	CbGbCtD
Levothyroxine—SERPINA7—vertebral column—bone cancer	0.00707	0.331	CbGeAlD
Levothyroxine—TTR—vertebral column—bone cancer	0.00325	0.152	CbGeAlD
Levothyroxine—THRA—Nuclear Receptors—NR1I2—bone cancer	0.00206	0.0584	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptors—NR1I2—bone cancer	0.00206	0.0584	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—FEV—bone cancer	0.00197	0.0557	CbGpPWpGaD
Levothyroxine—THRA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00163	0.0461	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00163	0.0461	CbGpPWpGaD
Levothyroxine—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00124	0.0352	CbGpPWpGaD
Levothyroxine—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00116	0.0329	CbGpPWpGaD
Levothyroxine—SERPINA7—bone marrow—bone cancer	0.000991	0.0463	CbGeAlD
Levothyroxine—SERPINA7—spinal cord—bone cancer	0.000986	0.0461	CbGeAlD
Levothyroxine—THRA—connective tissue—bone cancer	0.000919	0.043	CbGeAlD
Levothyroxine—THRA—Generic Transcription Pathway—ZNF77—bone cancer	0.00083	0.0235	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—ZNF77—bone cancer	0.00083	0.0235	CbGpPWpGaD
Levothyroxine—SLCO1B1—Irinotecan Pathway—CYP3A4—bone cancer	0.000793	0.0225	CbGpPWpGaD
Levothyroxine—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00071	0.0201	CbGpPWpGaD
Levothyroxine—SLC7A5—connective tissue—bone cancer	0.000701	0.0328	CbGeAlD
Levothyroxine—TTR—connective tissue—bone cancer	0.000683	0.0319	CbGeAlD
Levothyroxine—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000679	0.0192	CbGpPWpGaD
Levothyroxine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000678	0.0192	CbGpPWpGaD
Levothyroxine—SLCO4C1—bone marrow—bone cancer	0.000638	0.0298	CbGeAlD
Levothyroxine—THRA—Endochondral Ossification—IGF1R—bone cancer	0.000638	0.0181	CbGpPWpGaD
Levothyroxine—THRA—tendon—bone cancer	0.000632	0.0295	CbGeAlD
Levothyroxine—THRB—tendon—bone cancer	0.000632	0.0295	CbGeAlD
Levothyroxine—Infertility—Methotrexate—bone cancer	0.000626	0.0547	CcSEcCtD
Levothyroxine—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000621	0.0176	CbGpPWpGaD
Levothyroxine—THRA—spinal cord—bone cancer	0.000609	0.0285	CbGeAlD
Levothyroxine—TTR—Extracellular matrix organization—PLOD2—bone cancer	0.000592	0.0168	CbGpPWpGaD
Levothyroxine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000582	0.0165	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00058	0.0165	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—FOLR1—bone cancer	0.000563	0.016	CbGpPWpGaD
Levothyroxine—SLC16A2—spinal cord—bone cancer	0.000552	0.0258	CbGeAlD
Levothyroxine—THRA—Endochondral Ossification—PLAU—bone cancer	0.00052	0.0147	CbGpPWpGaD
Levothyroxine—SLCO1C1—spinal cord—bone cancer	0.000507	0.0237	CbGeAlD
Levothyroxine—SLC7A5—tendon—bone cancer	0.000482	0.0225	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—bone cancer	0.000467	0.0218	CbGeAlD
Levothyroxine—SLC7A5—spinal cord—bone cancer	0.000465	0.0217	CbGeAlD
Levothyroxine—TTR—bone marrow—bone cancer	0.000455	0.0213	CbGeAlD
Levothyroxine—TTR—spinal cord—bone cancer	0.000453	0.0212	CbGeAlD
Levothyroxine—SLCO4A1—spinal cord—bone cancer	0.000406	0.019	CbGeAlD
Levothyroxine—THRA—Gene Expression—ZNF77—bone cancer	0.0004	0.0113	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—ZNF77—bone cancer	0.0004	0.0113	CbGpPWpGaD
Levothyroxine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000381	0.0108	CbGpPWpGaD
Levothyroxine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000358	0.0102	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000351	0.00994	CbGpPWpGaD
Levothyroxine—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000342	0.00971	CbGpPWpGaD
Levothyroxine—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00034	0.00963	CbGpPWpGaD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000334	0.00947	CbGpPWpGaD
Levothyroxine—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000329	0.00934	CbGpPWpGaD
Levothyroxine—THRA—Endochondral Ossification—MMP9—bone cancer	0.000308	0.00873	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000305	0.00866	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—LOX—bone cancer	0.000293	0.00829	CbGpPWpGaD
Levothyroxine—SLCO1A2—spinal cord—bone cancer	0.000291	0.0136	CbGeAlD
Levothyroxine—Wheezing—Cisplatin—bone cancer	0.000289	0.0253	CcSEcCtD
Levothyroxine—Body temperature increased—Carboplatin—bone cancer	0.000286	0.025	CcSEcCtD
Levothyroxine—THRB—Generic Transcription Pathway—NR1I2—bone cancer	0.000281	0.00797	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—NR1I2—bone cancer	0.000281	0.00797	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000276	0.00782	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000256	0.00726	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000256	0.00726	CbGpPWpGaD
Levothyroxine—Cardiac failure congestive—Cisplatin—bone cancer	0.000238	0.0208	CcSEcCtD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000234	0.00664	CbGpPWpGaD
Levothyroxine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000231	0.00655	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000221	0.00627	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000221	0.00627	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—SPARC—bone cancer	0.000219	0.00622	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000215	0.00609	CbGpPWpGaD
Levothyroxine—Irritability—Cisplatin—bone cancer	0.000206	0.018	CcSEcCtD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000206	0.00583	CbGpPWpGaD
Levothyroxine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000205	0.00581	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000202	0.00573	CbGpPWpGaD
Levothyroxine—Dehydration—Cisplatin—bone cancer	0.000201	0.0176	CcSEcCtD
Levothyroxine—THRA—Gene Expression—FUS—bone cancer	0.000195	0.00553	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—FUS—bone cancer	0.000195	0.00553	CbGpPWpGaD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000195	0.00553	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000185	0.00525	CbGpPWpGaD
Levothyroxine—Sweating increased—Cisplatin—bone cancer	0.000182	0.0159	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Cisplatin—bone cancer	0.000164	0.0143	CcSEcCtD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000164	0.00465	CbGpPWpGaD
Levothyroxine—Myocardial infarction—Cisplatin—bone cancer	0.000163	0.0143	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—SPARC—bone cancer	0.000155	0.00441	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—JUN—bone cancer	0.000155	0.0044	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—DHFR—bone cancer	0.000155	0.00438	CbGpPWpGaD
Levothyroxine—Coma—Methotrexate—bone cancer	0.000149	0.013	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—GNA11—bone cancer	0.000142	0.00403	CbGpPWpGaD
Levothyroxine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000142	0.00403	CbGpPWpGaD
Levothyroxine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00014	0.00398	CbGpPWpGaD
Levothyroxine—Coma—Epirubicin—bone cancer	0.00014	0.0122	CcSEcCtD
Levothyroxine—Flushing—Cisplatin—bone cancer	0.000139	0.0121	CcSEcCtD
Levothyroxine—ALB—Platelet degranulation—SPARC—bone cancer	0.000135	0.00384	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—NR1I2—bone cancer	0.000135	0.00384	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—NR1I2—bone cancer	0.000135	0.00384	CbGpPWpGaD
Levothyroxine—Arrhythmia—Cisplatin—bone cancer	0.000134	0.0117	CcSEcCtD
Levothyroxine—Alopecia—Cisplatin—bone cancer	0.000132	0.0115	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—bone cancer	0.000129	0.0113	CcSEcCtD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000129	0.00366	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—IL3—bone cancer	0.000129	0.00365	CbGpPWpGaD
Levothyroxine—Cardiac failure congestive—Epirubicin—bone cancer	0.000122	0.0107	CcSEcCtD
Levothyroxine—Tremor—Cisplatin—bone cancer	0.000122	0.0107	CcSEcCtD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000122	0.00345	CbGpPWpGaD
Levothyroxine—Increased appetite—Epirubicin—bone cancer	0.000118	0.0103	CcSEcCtD
Levothyroxine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000115	0.00327	CbGpPWpGaD
Levothyroxine—Hypoglycaemia—Epirubicin—bone cancer	0.000114	0.00994	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—bone cancer	0.000114	0.00994	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—bone cancer	0.000113	0.0099	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—bone cancer	0.000113	0.00989	CcSEcCtD
Levothyroxine—Convulsion—Cisplatin—bone cancer	0.000113	0.00985	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—bone cancer	0.000112	0.00982	CcSEcCtD
Levothyroxine—Anxiety—Cisplatin—bone cancer	0.00011	0.00965	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—bone cancer	0.000109	0.00955	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—bone cancer	0.000109	0.00955	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—bone cancer	0.000106	0.00922	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—bone cancer	0.000105	0.0092	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—bone cancer	0.000105	0.0092	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—bone cancer	0.000105	0.00919	CcSEcCtD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000105	0.00298	CbGpPWpGaD
Levothyroxine—Tachycardia—Cisplatin—bone cancer	0.000104	0.00906	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—bone cancer	0.000103	0.00902	CcSEcCtD
Levothyroxine—Hyperhidrosis—Cisplatin—bone cancer	0.000103	0.00897	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—bone cancer	0.000101	0.00883	CcSEcCtD
Levothyroxine—THRA—Gene Expression—EIF2S1—bone cancer	0.0001	0.00283	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—EIF2S1—bone cancer	0.0001	0.00283	CbGpPWpGaD
Levothyroxine—Muscular weakness—Epirubicin—bone cancer	9.79e-05	0.00855	CcSEcCtD
Levothyroxine—ABCB1—bone marrow—bone cancer	9.78e-05	0.00457	CbGeAlD
Levothyroxine—Cardiac arrest—Doxorubicin—bone cancer	9.76e-05	0.00853	CcSEcCtD
Levothyroxine—ABCB1—spinal cord—bone cancer	9.74e-05	0.00455	CbGeAlD
Levothyroxine—Mood swings—Doxorubicin—bone cancer	9.73e-05	0.0085	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Cisplatin—bone cancer	9.68e-05	0.00846	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—bone cancer	9.59e-05	0.00838	CcSEcCtD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	9.55e-05	0.00271	CbGpPWpGaD
Levothyroxine—Dehydration—Doxorubicin—bone cancer	9.55e-05	0.00835	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—NDUFA12—bone cancer	9.51e-05	0.00269	CbGpPWpGaD
Levothyroxine—Dyspnoea—Cisplatin—bone cancer	9.47e-05	0.00828	CcSEcCtD
Levothyroxine—TTR—Extracellular matrix organization—MMP2—bone cancer	9.4e-05	0.00267	CbGpPWpGaD
Levothyroxine—Angina pectoris—Epirubicin—bone cancer	9.34e-05	0.00817	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—bone cancer	9.06e-05	0.00791	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—bone cancer	8.88e-05	0.00776	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—bone cancer	8.76e-05	0.00766	CcSEcCtD
Levothyroxine—Feeling abnormal—Cisplatin—bone cancer	8.75e-05	0.00765	CcSEcCtD
Levothyroxine—THRB—Gene Expression—EZH2—bone cancer	8.68e-05	0.00246	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—EZH2—bone cancer	8.68e-05	0.00246	CbGpPWpGaD
Levothyroxine—Weight decreased—Epirubicin—bone cancer	8.68e-05	0.00758	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—bone cancer	8.65e-05	0.00756	CcSEcCtD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	8.5e-05	0.00241	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—PLAU—bone cancer	8.46e-05	0.0024	CbGpPWpGaD
Levothyroxine—Body temperature increased—Cisplatin—bone cancer	8.4e-05	0.00734	CcSEcCtD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.25e-05	0.00234	CbGpPWpGaD
Levothyroxine—Sweating—Epirubicin—bone cancer	8.2e-05	0.00717	CcSEcCtD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.17e-05	0.00232	CbGpPWpGaD
Levothyroxine—Weight decreased—Doxorubicin—bone cancer	8.03e-05	0.00702	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—NT5C3A—bone cancer	7.88e-05	0.00223	CbGpPWpGaD
Levothyroxine—Asthenia—Cisplatin—bone cancer	7.62e-05	0.00666	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—bone cancer	7.59e-05	0.00663	CcSEcCtD
Levothyroxine—SLCO1A2—Metabolism—NDUFA12—bone cancer	7.47e-05	0.00212	CbGpPWpGaD
Levothyroxine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	7.29e-05	0.00207	CbGpPWpGaD
Levothyroxine—Diarrhoea—Cisplatin—bone cancer	7.27e-05	0.00635	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—bone cancer	7.25e-05	0.00634	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—GRM4—bone cancer	7.23e-05	0.00205	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RGS1—bone cancer	7.23e-05	0.00205	CbGpPWpGaD
Levothyroxine—Flushing—Epirubicin—bone cancer	7.13e-05	0.00623	CcSEcCtD
Levothyroxine—TTR—Extracellular matrix organization—MMP9—bone cancer	7.07e-05	0.002	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.05e-05	0.002	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	6.96e-05	0.00197	CbGpPWpGaD
Levothyroxine—Arrhythmia—Epirubicin—bone cancer	6.86e-05	0.00599	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—bone cancer	6.78e-05	0.00593	CcSEcCtD
Levothyroxine—Vomiting—Cisplatin—bone cancer	6.75e-05	0.0059	CcSEcCtD
Levothyroxine—Rash—Cisplatin—bone cancer	6.7e-05	0.00585	CcSEcCtD
Levothyroxine—Dermatitis—Cisplatin—bone cancer	6.69e-05	0.00585	CcSEcCtD
Levothyroxine—TTR—Disease—ENO2—bone cancer	6.65e-05	0.00189	CbGpPWpGaD
Levothyroxine—Flushing—Doxorubicin—bone cancer	6.59e-05	0.00576	CcSEcCtD
Levothyroxine—Tension—Epirubicin—bone cancer	6.56e-05	0.00573	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—bone cancer	6.49e-05	0.00567	CcSEcCtD
Levothyroxine—SLCO1B1—Metabolism—NDUFA12—bone cancer	6.39e-05	0.00181	CbGpPWpGaD
Levothyroxine—Arrhythmia—Doxorubicin—bone cancer	6.35e-05	0.00555	CcSEcCtD
Levothyroxine—Nausea—Cisplatin—bone cancer	6.31e-05	0.00551	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—bone cancer	6.28e-05	0.00549	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—GRM1—bone cancer	6.27e-05	0.00178	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NT5C3A—bone cancer	6.19e-05	0.00175	CbGpPWpGaD
Levothyroxine—Convulsion—Methotrexate—bone cancer	6.19e-05	0.00541	CcSEcCtD
Levothyroxine—TTR—Disease—DHFR—bone cancer	6.17e-05	0.00175	CbGpPWpGaD
Levothyroxine—Agitation—Epirubicin—bone cancer	6.14e-05	0.00537	CcSEcCtD
Levothyroxine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	6.12e-05	0.00174	CbGpPWpGaD
Levothyroxine—Arthralgia—Methotrexate—bone cancer	6.08e-05	0.00531	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—bone cancer	6.07e-05	0.0053	CcSEcCtD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.04e-05	0.00171	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	6.01e-05	0.0017	CbGpPWpGaD
Levothyroxine—Nervousness—Doxorubicin—bone cancer	6.01e-05	0.00525	CcSEcCtD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.92e-05	0.00168	CbGpPWpGaD
Levothyroxine—Palpitations—Epirubicin—bone cancer	5.91e-05	0.00516	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—bone cancer	5.88e-05	0.00514	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—bone cancer	5.79e-05	0.00506	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—bone cancer	5.69e-05	0.00497	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—bone cancer	5.68e-05	0.00497	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—bone cancer	5.67e-05	0.00496	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—bone cancer	5.63e-05	0.00492	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—bone cancer	5.5e-05	0.00481	CcSEcCtD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	5.5e-05	0.00156	CbGpPWpGaD
Levothyroxine—Palpitations—Doxorubicin—bone cancer	5.46e-05	0.00478	CcSEcCtD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	5.39e-05	0.00153	CbGpPWpGaD
Levothyroxine—Shock—Epirubicin—bone cancer	5.37e-05	0.00469	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—bone cancer	5.36e-05	0.00468	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—bone cancer	5.32e-05	0.00465	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—bone cancer	5.31e-05	0.00464	CcSEcCtD
Levothyroxine—SLCO1B1—Metabolism—NT5C3A—bone cancer	5.29e-05	0.0015	CbGpPWpGaD
Levothyroxine—Hyperhidrosis—Epirubicin—bone cancer	5.27e-05	0.00461	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—bone cancer	5.27e-05	0.00461	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—bone cancer	5.26e-05	0.0046	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—bone cancer	5.25e-05	0.00459	CcSEcCtD
Levothyroxine—CYP2C8—Biological oxidations—GSTP1—bone cancer	5.24e-05	0.00148	CbGpPWpGaD
Levothyroxine—Dyspnoea—Methotrexate—bone cancer	5.2e-05	0.00454	CcSEcCtD
Levothyroxine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.17e-05	0.00146	CbGpPWpGaD
Levothyroxine—Confusional state—Doxorubicin—bone cancer	5.09e-05	0.00445	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—bone cancer	5.03e-05	0.00439	CcSEcCtD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	4.98e-05	0.00141	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—bone cancer	4.97e-05	0.00434	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—bone cancer	4.97e-05	0.00434	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—bone cancer	4.93e-05	0.00431	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—bone cancer	4.93e-05	0.0043	CcSEcCtD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.91e-05	0.00139	CbGpPWpGaD
Levothyroxine—Hyperhidrosis—Doxorubicin—bone cancer	4.88e-05	0.00426	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—bone cancer	4.86e-05	0.00425	CcSEcCtD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.84e-05	0.00137	CbGpPWpGaD
Levothyroxine—Feeling abnormal—Methotrexate—bone cancer	4.8e-05	0.0042	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—bone cancer	4.77e-05	0.00417	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—bone cancer	4.7e-05	0.00411	CcSEcCtD
Levothyroxine—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.67e-05	0.00132	CbGpPWpGaD
Levothyroxine—Urticaria—Methotrexate—bone cancer	4.63e-05	0.00405	CcSEcCtD
Levothyroxine—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	4.61e-05	0.00131	CbGpPWpGaD
Levothyroxine—Body temperature increased—Methotrexate—bone cancer	4.61e-05	0.00403	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—bone cancer	4.61e-05	0.00403	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.6e-05	0.00402	CcSEcCtD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.59e-05	0.0013	CbGpPWpGaD
Levothyroxine—Insomnia—Doxorubicin—bone cancer	4.56e-05	0.00399	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—bone cancer	4.5e-05	0.00393	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—bone cancer	4.49e-05	0.00393	CcSEcCtD
Levothyroxine—TTR—Disease—TGFBR2—bone cancer	4.47e-05	0.00127	CbGpPWpGaD
Levothyroxine—Gastrointestinal pain—Epirubicin—bone cancer	4.46e-05	0.0039	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—SMO—bone cancer	4.42e-05	0.00125	CbGpPWpGaD
Levothyroxine—Fatigue—Doxorubicin—bone cancer	4.35e-05	0.0038	CcSEcCtD
Levothyroxine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.34e-05	0.00123	CbGpPWpGaD
Levothyroxine—Urticaria—Epirubicin—bone cancer	4.33e-05	0.00379	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—bone cancer	4.31e-05	0.00377	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—bone cancer	4.31e-05	0.00377	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—bone cancer	4.18e-05	0.00365	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—bone cancer	4.16e-05	0.00363	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—bone cancer	4.13e-05	0.00361	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—bone cancer	4.12e-05	0.0036	CcSEcCtD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	4.1e-05	0.00116	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.09e-05	0.00116	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GNA11—bone cancer	4.04e-05	0.00115	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.03e-05	0.00114	CbGpPWpGaD
Levothyroxine—Urticaria—Doxorubicin—bone cancer	4.01e-05	0.0035	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—bone cancer	3.99e-05	0.00349	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—bone cancer	3.99e-05	0.00349	CcSEcCtD
Levothyroxine—Diarrhoea—Methotrexate—bone cancer	3.99e-05	0.00349	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—bone cancer	3.91e-05	0.00342	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—bone cancer	3.86e-05	0.00337	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—ATF1—bone cancer	3.76e-05	0.00106	CbGpPWpGaD
Levothyroxine—Diarrhoea—Epirubicin—bone cancer	3.73e-05	0.00326	CcSEcCtD
Levothyroxine—Vomiting—Methotrexate—bone cancer	3.71e-05	0.00324	CcSEcCtD
Levothyroxine—Rash—Methotrexate—bone cancer	3.68e-05	0.00321	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—bone cancer	3.67e-05	0.00321	CcSEcCtD
Levothyroxine—CYP2C8—Metabolism—NDUFA12—bone cancer	3.67e-05	0.00104	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL3—bone cancer	3.66e-05	0.00104	CbGpPWpGaD
Levothyroxine—Headache—Methotrexate—bone cancer	3.65e-05	0.00319	CcSEcCtD
Levothyroxine—ALB—Metabolism—NDUFA12—bone cancer	3.65e-05	0.00103	CbGpPWpGaD
Levothyroxine—Asthenia—Doxorubicin—bone cancer	3.62e-05	0.00316	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—bone cancer	3.57e-05	0.00312	CcSEcCtD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.53e-05	0.001	CbGpPWpGaD
Levothyroxine—Vomiting—Epirubicin—bone cancer	3.47e-05	0.00303	CcSEcCtD
Levothyroxine—Nausea—Methotrexate—bone cancer	3.46e-05	0.00303	CcSEcCtD
Levothyroxine—ALB—Folate Metabolism—TP53—bone cancer	3.46e-05	0.000979	CbGpPWpGaD
Levothyroxine—Diarrhoea—Doxorubicin—bone cancer	3.45e-05	0.00302	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—ENO2—bone cancer	3.45e-05	0.000978	CbGpPWpGaD
Levothyroxine—Rash—Epirubicin—bone cancer	3.44e-05	0.00301	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—bone cancer	3.44e-05	0.003	CcSEcCtD
Levothyroxine—Headache—Epirubicin—bone cancer	3.42e-05	0.00299	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—TP53—bone cancer	3.4e-05	0.000964	CbGpPWpGaD
Levothyroxine—Nausea—Epirubicin—bone cancer	3.24e-05	0.00283	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—bone cancer	3.21e-05	0.0028	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—DHFR—bone cancer	3.2e-05	0.000907	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NDUFA12—bone cancer	3.2e-05	0.000906	CbGpPWpGaD
Levothyroxine—Rash—Doxorubicin—bone cancer	3.18e-05	0.00278	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—bone cancer	3.18e-05	0.00278	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—bone cancer	3.16e-05	0.00276	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—TGFBR2—bone cancer	3.13e-05	0.000888	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SPARC—bone cancer	3.1e-05	0.000878	CbGpPWpGaD
Levothyroxine—TTR—Disease—KIT—bone cancer	3.05e-05	0.000865	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.04e-05	0.000862	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NT5C3A—bone cancer	3.04e-05	0.000862	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NT5C3A—bone cancer	3.02e-05	0.000857	CbGpPWpGaD
Levothyroxine—Nausea—Doxorubicin—bone cancer	3e-05	0.00262	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—GNA11—bone cancer	2.99e-05	0.000848	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IGF1R—bone cancer	2.95e-05	0.000835	CbGpPWpGaD
Levothyroxine—TTR—Disease—BRAF—bone cancer	2.87e-05	0.000813	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—GNA11—bone cancer	2.83e-05	0.000803	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.81e-05	0.000797	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.77e-05	0.000786	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP3A4—bone cancer	2.71e-05	0.000769	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ENO2—bone cancer	2.71e-05	0.000768	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.7e-05	0.000765	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NT5C3A—bone cancer	2.65e-05	0.000751	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL3—bone cancer	2.57e-05	0.000728	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—DHFR—bone cancer	2.52e-05	0.000713	CbGpPWpGaD
Levothyroxine—TTR—Disease—MDM2—bone cancer	2.4e-05	0.000681	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GNA11—bone cancer	2.35e-05	0.000666	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GSTP1—bone cancer	2.32e-05	0.000658	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ENO2—bone cancer	2.32e-05	0.000657	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTGS2—bone cancer	2.32e-05	0.000657	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.25e-05	0.000639	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.17e-05	0.000616	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—DHFR—bone cancer	2.15e-05	0.00061	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KIT—bone cancer	2.14e-05	0.000606	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP3A4—bone cancer	2.13e-05	0.000604	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.12e-05	0.000601	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GNA11—bone cancer	2.01e-05	0.00057	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—BRAF—bone cancer	2.01e-05	0.00057	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFA12—bone cancer	1.97e-05	0.000558	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.96e-05	0.000556	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GSTP1—bone cancer	1.82e-05	0.000517	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP3A4—bone cancer	1.82e-05	0.000517	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.81e-05	0.000514	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLAU—bone cancer	1.68e-05	0.000478	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MDM2—bone cancer	1.68e-05	0.000477	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—bone cancer	1.64e-05	0.000466	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.63e-05	0.000463	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GSTP1—bone cancer	1.56e-05	0.000442	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.54e-05	0.000437	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—JUN—bone cancer	1.46e-05	0.000415	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—bone cancer	1.42e-05	0.000404	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ENO2—bone cancer	1.33e-05	0.000378	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ENO2—bone cancer	1.32e-05	0.000375	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.29e-05	0.000367	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—DHFR—bone cancer	1.24e-05	0.00035	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—DHFR—bone cancer	1.23e-05	0.000348	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—bone cancer	1.2e-05	0.000341	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ENO2—bone cancer	1.16e-05	0.000329	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GNA11—bone cancer	1.16e-05	0.000327	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—bone cancer	1.15e-05	0.000326	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GNA11—bone cancer	1.15e-05	0.000326	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—DHFR—bone cancer	1.08e-05	0.000305	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.05e-05	0.000297	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.04e-05	0.000295	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP3A4—bone cancer	1.04e-05	0.000295	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.04e-05	0.000294	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GNA11—bone cancer	1.01e-05	0.000285	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—bone cancer	9.66e-06	0.000274	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—bone cancer	9.44e-06	0.000268	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP3A4—bone cancer	9.12e-06	0.000259	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—bone cancer	8.96e-06	0.000254	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—bone cancer	8.91e-06	0.000252	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—bone cancer	8.08e-06	0.000229	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—bone cancer	7.8e-06	0.000221	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ENO2—bone cancer	7.15e-06	0.000203	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—bone cancer	6.77e-06	0.000192	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—DHFR—bone cancer	6.63e-06	0.000188	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GNA11—bone cancer	6.2e-06	0.000176	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—bone cancer	4.81e-06	0.000136	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—bone cancer	4.64e-06	0.000132	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—bone cancer	4.61e-06	0.000131	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—bone cancer	4.04e-06	0.000115	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—bone cancer	2.49e-06	7.06e-05	CbGpPWpGaD
